Two‐year follow‐up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell...

por Yen, Chia‐Jui, Kiyota, Naomi, Hanai, Nobuhiro, Takahashi, Shunji, Yokota, Tomoya, Iwae, Shigemichi, Shimizu, Yasushi, Hong, Ruey‐Long, Goto, Masahiro, Kang, Jin‐Hyoung, Li, Wing Sum Kenneth, Ferris, Robert L., Gillison, Maura, Endo, Toshimitsu, Jayaprakash, Vijayvel, Tahara, Makoto
Publicado 2020